Guardian Pharmacy Services completes $213.9 million follow-on public offering, including “synthetic secondary” transaction

Client(s) Guardian Pharmacy Services, Inc.

Jones Day represented Guardian Pharmacy Services, Inc. (NYSE: GRDN), a leading long-term care pharmacy services company, in connection with its $213.9 million underwritten follow-on public offering. The offering consisted of a secondary offering of 5,880,000 shares of Class A Common Stock by selling stockholders and a primary offering of 1,020,000 shares of Class A Common Stock, at a public offering price of $31.00 per share. The primary offering is considered non-dilutive, as Guardian used its net proceeds to repurchase 1,020,000 outstanding shares of Class A Common Stock from certain stockholders in a “synthetic secondary” transaction.